124 related articles for article (PubMed ID: 18618381)
1. [Immune-mediated hemolytic anemia under oxaliplatin].
Gundling F; Tiller M; Fuchs M; Schepp W
Z Gastroenterol; 2008 Jul; 46(7):695-9. PubMed ID: 18618381
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
Ogura T; Tajika M; Niwa Y; Kawai H; Kondo S; Sawaki A; Mizuno N; Hara K; Hijioka S; Nakamura M; Higuchi K; Goto H; Yamao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1712-9. PubMed ID: 21971145
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
5. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.
Lai JI; Wang WS
Pharm World Sci; 2009 Oct; 31(5):538-541. PubMed ID: 19588266
[TBL] [Abstract][Full Text] [Related]
6. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
[TBL] [Abstract][Full Text] [Related]
7. An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL
Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
9. Immunohemolytic anemia following oxaliplatin administration.
Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
[No Abstract] [Full Text] [Related]
10. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
[TBL] [Abstract][Full Text] [Related]
11. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.
Noronha V; Burtness B; Murren J; Duffy TP
Clin Colorectal Cancer; 2005 Nov; 5(4):283-6. PubMed ID: 16356307
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced renal tubular vacuolization.
Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated pancytopenia induced by oxaliplatin: a case report.
Fontão-Wendel R; Hoff PM; Lazar A; Freitas D; Novis Y; Patah P; Tsujita M; Balthazar A; Pierroti M; Wendel S
Transfusion; 2010 Jul; 50(7):1453-9. PubMed ID: 20210930
[TBL] [Abstract][Full Text] [Related]
15. Cold antibody autoimmune hemolytic anemia following varicella infection.
Carvalho G; D'silva A; Chandran P; Manuel K; Kinglsey ; Basheer A
Indian J Pathol Microbiol; 2023; 66(1):188-190. PubMed ID: 36656239
[TBL] [Abstract][Full Text] [Related]
16. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.
Kamesaki T; Toyotsuji T; Kajii E
Am J Hematol; 2013 Feb; 88(2):93-6. PubMed ID: 23169533
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
[TBL] [Abstract][Full Text] [Related]
18. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review.
Forcello NP; Khubchandani S; Patel SJ; Brahaj D
J Oncol Pharm Pract; 2015 Apr; 21(2):148-56. PubMed ID: 24500808
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]